PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Research & Development: Rp0 Mil (TTM As of Mar. 2026)


ISX:PRAY PT Famon Awal Bros Sedaya Tbk ISX:PRAY
86 GF Score
Price Rp680.00
GF Value Rp873.79
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is PT Famon Awal Bros Sedaya Tbk Research & Development?

PT Famon Awal Bros Sedaya Tbk ISX:PRAY +1.49% 86 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:PRAY with a GF Score™ of 86/100 and a GF Value™ of Rp873.79 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Famon Awal Bros Sedaya Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT Famon Awal Bros Sedaya Tbk  (ISX:PRAY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Famon Awal Bros Sedaya Tbk Research & Development Related Terms

PT Famon Awal Bros Sedaya Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Famon Awal Bros Sedaya Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Famon Awal Bros Sedaya Tbk Research & Development Chart

PT Famon Awal Bros Sedaya Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

PT Famon Awal Bros Sedaya Tbk Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:PRAY
86GF Score
PT Famon Awal Bros Sedaya Tbk ISX:PRAY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Famon Awal Bros Sedaya Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors.
Is PT Famon Awal Bros Sedaya Tbk's Research & Development too high?
PT Famon Awal Bros Sedaya Tbk's current Research & Development is Rp0 Mil. Overall, PT Famon Awal Bros Sedaya Tbk has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Famon Awal Bros Sedaya Tbk's Research & Development compare to HCA and THC?
PT Famon Awal Bros Sedaya Tbk's Research & Development of Rp0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors. PT Famon Awal Bros Sedaya Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Famon Awal Bros Sedaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp873.79, compared to a current price of Rp680.00 — trading 22.2% below its estimated fair value. The current Research & Development is Rp0 Mil. PT Famon Awal Bros Sedaya Tbk's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Famon Awal Bros Sedaya Tbk (ISX:PRAY), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Overvalued in 2026?

Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk stock appears to be undervalued. The current stock price of Rp680.00 is trading 22.2% below its estimated GF Value™ of Rp873.79. GuruFocus considers PT Famon Awal Bros Sedaya Tbk to be Modestly Undervalued.

Key valuation signals for ISX:PRAY:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp873.79 vs. price of Rp680.00 (22.2% below fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the ISX:PRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Famon Awal Bros Sedaya Tbk Business Description

Address Ruko Mega Grosir Cempaka Mas Blok N/21, Kel. Sumur Batu, Kec. Kemayoran, Jakarta Pusat, Jakarta, IDN, 10640
PT Famon Awal Bros Sedaya Tbk operates as a hospital. The company7 provides comprehensive health services for Indonesians and foreign nationals (foreigners) and provides patient services with guarantees from companies, insurance, BPJS, and personal payments. Its hospital network has spread across different cities in Indonesia, including Jakarta, Bekasi, Tangerang, Semarang, Sukabumi, Makassar, Palangkaraya, and Pangkal Pinang. The services that it provides for patients include heart and blood vessel service centers, mother and child services, sports clinic & orthopedic services, cancer services, eye care centers & urology centers. The company's segments are Java; Kalimantan dan/ and Sulawesi; and Sumatera. It derives maximum revenue from Jawa.
86GF Score

Get the complete analysis for ISX:PRAY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp680.00
Price
Rp873.79
GF Value